Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. - Wikidata - wikimedia - TriplyDB

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

http://www.wikidata.org/entity/Q43276156

about

Update on positron emission tomography for imaging of prostate cancer SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Update on advances in molecular PET in urological oncology Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.Prostate-specific antigen and prostate-specific antigen velocity as threshold indicators in 11C-acetate PET/CTAC scanning for prostate cancer recurrence.Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.Management of urological malignancies: Has positron emission tomography/computed tomography made a difference?Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse.[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.PET and PET/CT in radiation treatment planning for prostate cancer.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.Serum tumor markers and PET/CT imaging for tumor recurrence detection.11C-choline PET/CT and PSA kinetics.Imaging treated prostate cancer.Choline PET/CT for imaging prostate cancer: an update.PET/MR in prostate cancer: technical aspects and potential diagnostic value.Individualized image-based lymph node irradiation for prostate cancer.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.PSMA PET and Radionuclide Therapy in Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.68Ga-PSMA PET/CT imaging in recurrent prostate cancer: Where are we now?11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?Evaluation of androgen-induced effects on the uptake of [18F]FDG, [11C]choline and [11C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model.Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy.Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy.(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer.A fully-automated one-pot synthesis of [18F]fluoromethylcholine with reduced dimethylaminoethanol contamination via [18F]fluoromethyl tosylate.

P2860

Q27026828-CF779B73-C05A-4576-95D8-B84A509D9012 Q30828977-CFA94D4C-0814-4D5F-839D-C7D95782E6EC Q31003607-EF1126AB-719F-4E3A-A90C-138D376F2FC9 Q33625389-6B9F831C-9361-48B6-84B3-C6E472DFF1B0 Q33711641-F0CADE1F-6E4B-4FD1-BCB6-96674AD8613C Q34062324-0BC13D5E-BDD0-4836-A154-1B8DB5EF0980 Q34228828-C3006D24-FAEF-4168-96B9-E7C43E7CFC6B Q34990800-830C6D4E-1224-4334-89E1-24DB646ABB9B Q35155500-0102D736-F440-4B75-8915-A9F50157C3C8 Q35195300-6F1BE371-71F8-448C-93D7-08C7ADCD4D91 Q35849174-9E2A7C27-AB48-481B-B7EF-A2B20AA55418 Q36489655-A0C878BC-E29A-4EB0-ABC6-006E73C1F52E Q37086178-BD01C98D-5C52-4B99-BF3E-AE5A7D73EE41 Q37909361-68784C84-F607-4CAD-ABAB-BA3307F7108C Q37973351-A4661799-8F54-4B4D-A495-080C35A8E28C Q38004182-55530A94-D922-4B97-BFAE-0D8C3CD5EAED Q38082682-DC13CECC-D9F2-4DB6-B1DC-BDBDE5EE909B Q38098442-243E7920-F05D-421C-9680-012DA0449AB0 Q38100661-8D09C160-33A1-4934-84B7-94DD8048B74F Q38103180-5BCD420D-618F-4950-BFB5-EC9E5CECF72C Q38109083-4049CCB1-4389-4352-9E01-106D6D90E4D0 Q38109812-0EC7852B-3AEC-44EB-85F4-66D70F388F52 Q38190115-832D7924-8037-4EA8-B223-5EACCD29184D Q38321182-026C0E53-6B35-49F9-BDD6-9019BED69B64 Q38636446-D83B339F-0F0A-4330-BF54-953D1344ECDC Q38833159-CAA5090B-5546-4B1B-9C0C-73B8CF5B9DD0 Q38946874-AFD31FCF-9CC2-4464-90B9-4F2C79E788DC Q38966705-EAE22B8C-0860-4B94-82C1-8B402896B6DB Q38996907-9BEFC7D8-5892-4D31-8AA6-EA15A4FD3898 Q39003089-2BA2427C-935B-4105-ADDB-D4BB3AD559D1 Q39242140-5D3AAF76-35E2-4368-8320-1E6DCAF69CA5 Q39276928-F00A0169-AF59-499A-8535-C3FADAF6BCDB Q39293042-81F711B9-A8ED-428F-AAF1-9255E5C9311D Q39512219-0FCBC185-B027-4CB8-9CAE-FCB641971FC6 Q40275645-C326661D-0BBA-4831-AE86-4A2242DFC72C Q40661091-09FC1C3D-23A2-4439-8D15-E53AEDD1920A Q41021179-A5364ACF-8C33-495F-800B-2C60236747C3 Q41161118-C7B29A7D-B9BE-481B-8F85-B46FFDBEB6EE Q41563753-BA26981C-766B-4E87-83FB-B1071D52D4B0 Q41840589-51718413-CD28-4E41-AEDD-5A32B39ECDFB

P2860

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

http://www.wikidata.org/entity/Q43276156

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Predictive factors of [

@nl

Predictive factors of [(11)C]c ...... e after radical prostatectomy.

@en

type

label

Predictive factors of [

@nl

Predictive factors of [(11)C]c ...... e after radical prostatectomy.

@en

prefLabel

Predictive factors of [

@nl

Predictive factors of [(11)C]c ...... e after radical prostatectomy.

@en

P1433

Q43276156-837AAD55-13B4-490E-BB09-A9847897A862

P1476

Q43276156-E7C71DB7-A976-4058-9C4C-4E63E3A97845

P2093

Q43276156-06B5BE05-4FFA-46FF-AF0D-359D5CB74880

Q43276156-12A40307-E559-43BB-A292-80F7B5993D7A

Q43276156-18043766-CF4F-4FEC-AE2D-278953468403

Q43276156-74426924-B2B1-4073-B617-133F3B2D6162

Q43276156-8D76F742-B235-4571-8EAA-FE6BFAF04406

Q43276156-A19F6BE8-1CDF-4254-B9F7-4D527938A5F1

Q43276156-A9ABA1CA-A283-413E-888F-4C434E72A48B

Q43276156-BABA2A5A-BE17-4FEE-A0E1-C42AF7C289E9

Q43276156-BF3BE73A-B8B4-429E-931C-27960F9AC9CC

P2860

Q43276156-F9952266-9B5D-4D1E-BBC9-BB54D644A018

P2888

Q43276156-D01D3CAE-C31A-4CA7-8BCC-D439918EFFBE

P304

Q43276156-F2CDC49C-FDFE-4750-9069-4B6F126F653D

P31

Q43276156-6EA0F939-D324-4806-9C1A-E5EEBF7E02A1

P356

Q43276156-160B5989-7BFA-4DC2-8EEB-25CAF748A73E

P433

Q43276156-5FD762C9-C4D2-4377-85DC-84B84A2170ED

P478

Q43276156-8BF1964F-3251-4781-A12D-9543661CBACB

P50

Q43276156-7E23C0E7-640C-4048-9B1B-0481AF4BE6B2

Q43276156-A7399AD7-97DF-4F9F-9936-95572B7FCD12

P577

Q43276156-6C7CBF2E-C18C-4C7F-9143-17E373117161

P698

Q43276156-5B13CAD1-F98A-4DE7-A05C-1C4D0B36C50F

P356

S00259-009-1253-3

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Predictive factors of [(11)C]c ...... e after radical prostatectomy.

@en

P2093

Cristina Messa

http://www.w3.org/2001/XMLSchema#string

Elisa Coradeschi

http://www.w3.org/2001/XMLSchema#string

Ferruccio Fazio

http://www.w3.org/2001/XMLSchema#string

Giampiero Giovacchini

http://www.w3.org/2001/XMLSchema#string

Luigi Gianolli

http://www.w3.org/2001/XMLSchema#string

Nadia Di Muzio

http://www.w3.org/2001/XMLSchema#string

Patrizio Rigatti

http://www.w3.org/2001/XMLSchema#string

Valentino Bettinardi

http://www.w3.org/2001/XMLSchema#string

Vincenzo Scattoni

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database.

P2888

s00259-009-1253-3

P304

301-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-009-1253-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Cesare Cozzarini

P577

2009-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19756592

http://www.w3.org/2001/XMLSchema#string